<DOC>
	<DOCNO>NCT00730418</DOCNO>
	<brief_summary>In study , investigate change expression alpha adrenergic receptor prostate tissue 2-yr medication period man benign prostatic hyperplasia . And also evaluate efficacy safety 24 mo-treatment doxazosin ( 4mg , 8mg )</brief_summary>
	<brief_title>Effects Chronic Use Doxazosin Men With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>To compare expression alpha-1 adrenergic receptor , use various methodology - Real-time RT-PCR - Radioligand receptor bind - Western blot - Immunohistochemistry</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Adrenergic Agents</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<criteria>50 yr great International prostatic symptom score &gt; = 8 Maximal flow rate &lt; 15mL/sec baseline PSA 2.510 ng/mL Pathologically proven BPH No medication history BPH Able give fully inform consent Previous use alphablocker , 5alpha reductase inhibitor Previous surgery BPH Urologic cancer history Urethral stricture baseline PSA &gt; 10ng/mL BP &lt; 90/70 mmHg Orthotopic hypotension syncope Serum Cr &gt; 2.0 mg/dl , alanine aminotransferase &gt; 1.5 time normal limit Bacterial prostatitis within 1 year Urinary tract infection ( UTI ) 2 time within 1 year Active UTI prostate biopsy within 1 month Unable void Ped use incontinence Hypersensitivity alphablocker include quinazoline Unstable angina , Myocardial infarction , cerebrovascular accident within 6 month Neurogenic bladder dysfunction ( ex . multiple sclerosis , Parkinson 's disease , Spinal injury etc . ) Psychiatric problem Alcohol abuse drug abuse history Severe comorbidities unable perform longterm trial seem appropriate study reason</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Benign Prostatic Hyperplasia</keyword>
	<keyword>alpha Adrenergic Blockers</keyword>
	<keyword>alpha-1 Adrenergic Receptor</keyword>
</DOC>